Abbott Laboratories (ABT)vsCanadian Natural Resources Ltd (CNQ)
ABT
Abbott Laboratories
$103.99
-0.55%
HEALTHCARE · Cap: $180.82B
CNQ
Canadian Natural Resources Ltd
$50.09
+2.92%
ENERGY · Cap: $101.52B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 14% more annual revenue ($44.33B vs $38.76B). CNQ leads profitability with a 27.9% profit margin vs 14.7%. ABT appears more attractively valued with a PEG of 1.52. CNQ earns a higher WallStSmart Score of 67/100 (B-).
ABT
Buy51
out of 100
Grade: C-
CNQ
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-312.2%
Fair Value
$25.23
Current Price
$103.99
$78.76 premium
Margin of Safety
+76.8%
Fair Value
$175.50
Current Price
$50.09
$125.41 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.6%
Generating 2.6B in free cash flow
Revenue surging 150.0% year-over-year
Earnings expanding 372.3% YoY
Large-cap with strong market position
Every $100 of equity generates 26 in profit
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.4% revenue growth
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : CNQ
The strongest argument for CNQ centers on Revenue Growth, EPS Growth, Market Cap. Profitability is solid with margins at 27.9% and operating margin at 19.6%. Revenue growth of 150.0% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, Revenue Growth.
Bear Case : CNQ
The primary concerns for CNQ are PEG Ratio.
Key Dynamics to Monitor
ABT profiles as a value stock while CNQ is a growth play — different risk/reward profiles.
CNQ carries more volatility with a beta of 1.06 — expect wider price swings.
CNQ is growing revenue faster at 150.0% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
CNQ scores higher overall (67/100 vs 51/100), backed by strong 27.9% margins and 150.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Canadian Natural Resources Ltd
ENERGY · OIL & GAS E&P · USA
Canadian Natural Resources Limited acquires, explores, develops, produces, markets and sells crude oil, natural gas and natural gas liquids (NGL). The company is headquartered in Calgary, Canada.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?